Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study

Background: The rate of loco-regional recurrences for locally advanced head and neck squamous cell carcinoma (HNSCC) following standard treatment reaches up to 50%, accompanied by a probability of 20% to develop a second primary tumor in the head and neck region. Methods: Ten patients with inoperabl...

Descripció completa

Dades bibliogràfiques

Autors principals:	Alev Altay-Langguth, Panagiotis Balermpas, Christian Brandts, Sven Balster, Shahram Ghanaati, Ria Winkelmann, Iris Burck, Franz Rödel, Daniel Martin, Claus Rödel, Jens von der Grün
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2021-05-01
Col·lecció:	Clinical and Translational Radiation Oncology
Matèries:	Re-irradiation Radiotherapy Immunotherapy Nivolumab Head and neck cancer
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S240563082100029X
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!